New FDA Testosterone Warning Announced – Lawyers for National Testim Lawsuits Increase FDA Testosterone Warning Information at TestimTestosteroneLawsuitCenter.com

Attorneys representing clients throughout the country in Testim testosterone lawsuits with The Onder Law Firm offer timely Testim lawsuit news – Updated FDA testosterone warning information is now available.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

St. Louis, MO (PRWEB) June 26, 2014

Lawyers handling national Testim testosterone lawsuit claims are offering details of the new FDA testosterone warning* for Testim and other qualifying testosterone replacement therapies at their Testim Testosterone Lawsuit Center website. A new FDA testosterone warning was made public last week, warning clinicians and patients that use of testosterone replacement products such as Testim has been connected with blood clots in the veins, or venous thromboembolism, which can result in life-threatening health problems such as deep vein thrombosis and pulmonary embolism. The FDA testosterone warning requires Testim and other testosterone producers to add a new blood clot warning to the drug’s label.

This is not the first time testosterone drugs like Testim have been subject to an FDA warning. The drugs’ labels already caution consumers of the risk of venous blood clots as a result of polycythemia, or an abnormally high red blood cell concentration. The new warning is in regards to the risk of venous blood clots that occur in patients taking Testim who do not have high levels of red blood cells. This FDA testosterone warning constitutes an expansion of the previous blood clot warnings for venous thromboembolism in patients taking testosterone replacement therapies.

Testosterone drugs such as Testim are also the subject of an FDA investigation due to research showing that men who take testosterone boosting drugs face a heightened risk for heart attack and stroke. While the FDA has not yet confirmed the link or mandated a testosterone heart attack and stroke warning on product labels, peer-reviewed studies cited by the FDA in its testosterone warning for heart attack and stroke** say that men face a two- to three-fold increase in the risk for cardiovascular problems while taking testosterone products such as Testim. Heart attack and stroke in testosterone patients, the FDA warning says, are thought to be caused by blood clots in the arteries.

At this time, the only Testim lawsuits in federal courts are those alleging a link between cardiovascular problems such as heart attack and stroke and testosterone. Court documents*** available to the public reveal that 45 testosterone lawsuits have already been filed related to claims of heart attack, stroke, and death. Testim lawsuits making claims of heart attack and stroke are being consolidated with lawsuits for all other testosterone replacement drugs; together the suits will be considered as a Multi-District Litigation in the Northern Illinois U.S. District Court in Chicago (In re: Testosterone Replacement Therapy Products Liability Litigation, Case MDL 2545).

The potential for heart attack and stroke in patients using testosterone therapies such as Testim is the subject of the current FDA testosterone investigation announced in the January 31, 2014 FDA testosterone warning. The most recent FDA testosterone warning news concerns a separate class of health risks. Testim lawsuits for claims related to venous blood clots will not be included in the testosterone lawsuit MDL for heart attack and stroke claims.

No amount of money can compensate families effectively for the loss of loved one, but the threat of Testim lawsuits may pressure Auxilium, the maker of Testim, to prioritize consumer safety in the future. Attorneys representing clients in Testim lawsuits with The Onder Law Firm believe qualifying persons may be entitled to real compensation through a Testim lawsuit against Auxilium. Lawyers handling Testim lawsuits announce no-cost, no-obligation case review to persons or family members of those who have suffered heart attack, stroke, or another serious health problem possibly related to Testim or another testosterone drug. To receive a free, no-obligation Testim case review with an experienced attorney, contact the firm via its Testim Testosterone Lawsuit Center website.

The Onder Law Firm welcomes Testim lawsuit or other testosterone case inquiries from law firms in regards to handling them or working as co-counsel.

About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from lawyers handling Testim testosterone lawsuits at http://www.testimtestosteronelawsuitcenter.com.

*fda.gov/drugs/drugsafety/ucm401746.htm
**fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm384225.htm
***jpml.uscourts.gov/sites/jpml/files/MDL-2545-Initial_Transfer-05-14.pdf


Contact

  • Michael Gudeman
    Gudeman Group
    +1 (314) 614-8709
    Email